Health products policy and standards
Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain.

Blood and Other Products of Human Origin

WHO develops norms, standards, technical guidance and high-level strategic recommendations and provides scientific assessment of current and emerging threats on ensuring availability, safety and quality of blood products and works to improve global access to transplantation of human organs and tissues. The work supports strengthening of country and regional capacity for the supply of quality-assured safe blood products and transplant services improving access to these life-saving treatments.

Partners and Collaborators

Other Relevant Teams/Programmes

WHO Collaborating Centres

WHO collaborating centres are institutions such as research institutes, parts of universities or academies, which are designated by the Director-General to carry out activities in support of the Organization's programmes. Currently there are 6 WHO collaborating centres in blood and transplantation. 

 

NSAs in Official Relations

Non-State Actors (NSAs) are nongovernmental organizations, private sector entities, philanthropic foundations and academic institutions. “Official relations” is a privilege that the Executive Board may grant to NSAs that have had and continue to have a sustained and systematic engagement in the interest of the Organization. The aims and activities of all these entities shall be in conformity with the spirit, purposes and principles of WHO’s Constitution, and they shall contribute significantly to the advancement of public health. Currently there are 5 NSAs in official relations with WHO in blood and transplantation. 

Latest Publications

All →

Our Team

Dr. Yuyun Maryuningsih

Team lead - Blood and Other Products of Human Origin

Email: maryuningsihy@who.int